Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Oct;46(10):1924-1926.
doi: 10.1007/s00134-020-06177-1. Epub 2020 Jul 15.

Prediction of outcome of nasal high flow use during COVID-19-related acute hypoxemic respiratory failure

Noémie Zucman  1 , Jimmy Mullaert  2 , Damien Roux  3 , Oriol Roca  4 , Jean-Damien Ricard  5 ; Contributors
Collaborators, Affiliations
Comment

Prediction of outcome of nasal high flow use during COVID-19-related acute hypoxemic respiratory failure

Noémie Zucman et al. Intensive Care Med. 2020 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

JDR received travel expenses and accommodation coverage from Fisher & Paykel Healthcare to attend scientific meetings. Fisher & Paykel Healthcare provided support for the ongoing High Flow ACRF trial (NCT03406572) but took no part in design or conduct of the study. OR received speaker fees from Air Liquide. His institution received consultancy fees from Hamilton Medical. DR received personal fees from Astellas. Other authors have no conflict of interest.

Figures

Fig. 1
Fig. 1
Cumulative incidence of orotracheal intubation for all at-risk patients (N = 60) and after 4 h of NHF (N = 45) stratified on ROX-H0H4 (landmark at H4). NHF, nasal high flow. ROX-H0H4 was defined as the latest value of the ROX index within the first 4 h after NHF initiation
See this image and copyright information in PMC

Comment on

References

    1. Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323:1574. doi: 10.1001/jama.2020.5394. - DOI - PMC - PubMed
    1. Alhazzani W, Møller MH, Arabi YM, et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19) Intensive Care Med. 2020;46:854–887. doi: 10.1007/s00134-020-06022-5. - DOI - PMC - PubMed
    1. Gattinoni L, Chiumello D, Caironi P, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020;46:1099–1102. doi: 10.1007/s00134-020-06033-2. - DOI - PMC - PubMed
    1. Roca O, Caralt B, Messika J, et al. An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy. Am J Respir Crit Care Med. 2019;199:1368–1376. doi: 10.1164/rccm.201803-0589OC. - DOI - PubMed
    1. Ottestad W, Søvik S. COVID-19 patients with respiratory failure: what can we learn from aviation medicine? Br J Anaesth. 2020 doi: 10.1016/j.bja.2020.04.012. - DOI - PMC - PubMed